Pazopanib in relapsed osteosarcoma patients: report on 15 cases

Authors

  • Alessandra Longhi Department of Chemotherapy, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy
  • Anna Paioli Department of Chemotherapy, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy
  • Emanuela Palmerini Department of Chemotherapy, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy
  • Marilena Cesari Department of Chemotherapy, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy
  • Massimo E. Abate Department of Chemotherapy, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy
  • Elisabetta Setola Department of Chemotherapy, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy
  • Paolo Spinnato Department of Radiology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy
  • Davide Donati Orthopedic Surgery, Orthopedic Oncologic Surgery, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy
  • Ivar Hompland Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway
  • Kjetil Boye Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway

DOI:

https://doi.org/10.1080/0284186X.2018.1503714

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2019-01-02

How to Cite

Longhi, A., Paioli, A., Palmerini, E., Cesari, M., Abate, M. E., Setola, E., … Boye, K. (2019). Pazopanib in relapsed osteosarcoma patients: report on 15 cases. Acta Oncologica, 58(1), 124–128. https://doi.org/10.1080/0284186X.2018.1503714

Issue

Vol. 58 No. 1 (2019): Acta Oncologica

Section

Articles